Literature DB >> 16517918

Emergence of linezolid resistance in the vancomycin-resistant Enterococcus faecium multilocus sequence typing C1 epidemic lineage.

Maria Grazia Bonora1, Maurizio Solbiati, Erminia Stepan, Antonella Zorzi, Aldo Luzzani, Maria Rosaria Catania, Roberta Fontana.   

Abstract

A relatively high rate of vancomycin-resistant Enterococcus faecium not susceptible to linezolid was observed in intensive care unit patients. Linezolid-resistant isolates carried the G2576T mutation in the 23S rRNA gene, belonged to different clones, and shared the same allelic profile, which clusters in the C1 multilocus sequence typing epidemic lineage.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16517918      PMCID： PMC1393143          DOI： 10.1128/JCM.44.3.1153-1155.2006

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  13 in total

1.  Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium.

Authors:  Inmaculada A Herrero; Nicolas C Issa; Robin Patel
Journal:  N Engl J Med       Date:  2002-03-14       Impact factor: 91.245

2.  Detection of oxazolidinone-resistant Enterococcus faecalis and Enterococcus faecium strains by real-time PCR and PCR-restriction fragment length polymorphism analysis.

Authors:  Neil Woodford; Luke Tysall; Cressida Auckland; Mark W Stockdale; Andrew J Lawson; Rachel A Walker; David M Livermore
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

3.  Rapid detection and estimation by pyrosequencing of 23S rRNA genes with a single nucleotide polymorphism conferring linezolid resistance in Enterococci.

Authors:  Alistair Sinclair; Catherine Arnold; Neil Woodford
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

4.  Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis.

Authors:  S H Marshall; C J Donskey; R Hutton-Thomas; R A Salata; L B Rice
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

Review 5.  Antimicrobial resistance to linezolid.

Authors:  Venkata G Meka; Howard S Gold
Journal:  Clin Infect Dis       Date:  2004-09-10       Impact factor: 9.079

6.  Risk factors associated with the development of infection with linezolid- and vancomycin-resistant Enterococcus faecium.

Authors:  Manjunath P Pai; Keith A Rodvold; Paul C Schreckenberger; Ronald D Gonzales; Jennifer M Petrolatti; John P Quinn
Journal:  Clin Infect Dis       Date:  2002-10-28       Impact factor: 9.079

7.  Resistance to linezolid: characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci.

Authors:  J Prystowsky; F Siddiqui; J Chosay; D L Shinabarger; J Millichap; L R Peterson; G A Noskin
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

8.  Multilocus sequence typing scheme for Enterococcus faecium.

Authors:  Wieger L Homan; David Tribe; Simone Poznanski; Mei Li; Geoff Hogg; Emile Spalburg; Jan D A Van Embden; Rob J L Willems
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

9.  CDC definitions for nosocomial infections, 1988.

Authors:  J S Garner; W R Jarvis; T G Emori; T C Horan; J M Hughes
Journal:  Am J Infect Control       Date:  1988-06       Impact factor: 2.918

10.  Vancomycin-resistant Enterococcus faecium isolates causing hospital outbreaks in northern Italy belong to the multilocus sequence typing C1 lineage.

Authors:  Maria Grazia Bonora; Marco Ligozzi; Maria De Fatima; Luciana Bragagnolo; Antonio Goglio; Gian Carlo Guazzotti; Roberta Fontana
Journal:  Microb Drug Resist       Date:  2004       Impact factor: 3.431
View more
  16 in total

1.  In vitro activities of the Rx-01 oxazolidinones against hospital and community pathogens.

Authors:  Laura Lawrence; Paul Danese; Joe DeVito; Francois Franceschi; Joyce Sutcliffe
Journal:  Antimicrob Agents Chemother       Date:  2008-03-03       Impact factor: 5.191

2.  Detection of mutations conferring resistance to linezolid in Enterococcus spp. by fluorescence in situ hybridization.

Authors:  Guido Werner; Melanie Bartel; Nele Wellinghausen; Andreas Essig; Ingo Klare; Wolfgang Witte; Sven Poppert
Journal:  J Clin Microbiol       Date:  2007-05-02       Impact factor: 5.948

3.  [Prevention and control of the spread of vancomycin-resistant enterococci: results of a workshop held by the German Society for Hygiene and Microbiology].

Authors:  R-P Vonberg; I F Chaberny; A Kola; F Mattner; S Borgmann; M Dettenkofer; D Jonas; A-M Fahr; I Klare; G Werner; K Weist; C Wendt; P Gastmeier
Journal:  Anaesthesist       Date:  2007-02       Impact factor: 1.041

4.  Outbreak of linezolid-resistant Staphylococcus haemolyticus in an Italian intensive care unit.

Authors:  A Mazzariol; G Lo Cascio; E Kocsis; L Maccacaro; R Fontana; G Cornaglia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-07-27       Impact factor: 3.267

Review 5.  Bacterial resistance: a sensitive issue complexity of the challenge and containment strategy in Europe.

Authors:  W T M Jansen; J T van der Bruggen; J Verhoef; A C Fluit
Journal:  Drug Resist Updat       Date:  2006-06-27       Impact factor: 18.500

6.  Phenylthiazole Antibacterial Agents Targeting Cell Wall Synthesis Exhibit Potent Activity in Vitro and in Vivo against Vancomycin-Resistant Enterococci.

Authors:  Haroon Mohammad; Waleed Younis; Lu Chen; Christine E Peters; Joe Pogliano; Kit Pogliano; Bruce Cooper; Jianan Zhang; Abdelrahman Mayhoub; Eric Oldfield; Mark Cushman; Mohamed N Seleem
Journal:  J Med Chem       Date:  2017-03-15       Impact factor: 7.446

7.  Efficacy of tigecycline alone and in combination with gentamicin in the treatment of experimental endocarditis due to linezolid-resistant Enterococcus faecium.

Authors:  Konstantinos Pontikis; Angelos Pefanis; Thomas Tsaganos; Ira-Maria Tzepi; Dionyssia-Pinelopi Carrer; Helen Giamarellou
Journal:  Antimicrob Agents Chemother       Date:  2013-04-15       Impact factor: 5.191

8.  Response to emerging infection leading to outbreak of linezolid-resistant enterococci.

Authors:  Marion A Kainer; Rose A Devasia; Timothy F Jones; Bryan P Simmons; Kelley Melton; Susan Chow; Joyce Broyles; Kelly L Moore; Allen S Craig; William Schaffner
Journal:  Emerg Infect Dis       Date:  2007-07       Impact factor: 6.883

9.  Revisiting Nitrofurantoin for Vancomycin Resistant Enterococci.

Authors:  Suneeta Meena; Sarita Mohapatra; Seema Sood; Benu Dhawan; Bimal Ku Das; Arti Kapil
Journal:  J Clin Diagn Res       Date:  2017-06-01

10.  JAID/JSC Guidelines for the Treatment of Respiratory Infectious Diseases: The Japanese Association for Infectious Diseases/Japanese Society of Chemotherapy - The JAID/JSC Guide to Clinical Management of Infectious Disease/Guideline-preparing Committee Respiratory Infectious Disease WG.

Authors:  Keiichi Mikasa; Nobuki Aoki; Yosuke Aoki; Shuichi Abe; Satoshi Iwata; Kazunobu Ouchi; Kei Kasahara; Junichi Kadota; Naoki Kishida; Osamu Kobayashi; Hiroshi Sakata; Masahumi Seki; Hiroki Tsukada; Yutaka Tokue; Fukumi Nakamura-Uchiyama; Futoshi Higa; Koichi Maeda; Katsunori Yanagihara; Koichiro Yoshida
Journal:  J Infect Chemother       Date:  2016-06-15       Impact factor: 2.211
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.